In a recent press release, Eli Lilly's management said that the U.S. incretin market, which includes drugs like Zepbound and Mounjaro, didn't grow as fast as it anticipated in the fourth quarter.

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Zepbound). A survey of neuro-ophthalmologists turned up seven cases of nonarteritic ischemic anterior optic neuropathy (NAION), one case of bilateral papillitis, and one case of paracentral acute ...

Rates for money-market mutual funds are also moving lower, but they're still giving many banks a run for their money. Money-market funds are not bank accounts, but super-safe investment ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

The measure of price increases targeted by the Federal Reserve sped up in December, reflecting a stubborn spell of inflation that remains modestly higher than the central bank's target. The ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

to your “injection” needle (usually 22–25 gauge) and proceed directly with your injection as shown in these videos. Injectable medication vials are packaged and labeled for single-use or multiuse.